Accelerated wound healing in diabetic ulcers by Sitagliptin - SitaDF

Medical University of Innsbruck0 个研究点目标入组 40 人开始时间: 2016年7月5日最近更新: 2016年10月10日

适应症

试验速览

暂无简介。

•-Typ 2 diabetic males and females > 18 years
•-= 1 diabetic foot ulcer measuring 1-20 cm2,
•-stable foot ulcer size over a period of = 2 weeks
•-HbA1c = 8% on treatment with insulin, metformin, sulfonylurea, SGLT-2 inhibitors, glinids, glitazones (single or combination therapy)
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 8
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 32

•-local signs of purulent infection at ulcer site
•-planned interventional or surgical treatment of a macrovascular disease in the lower limbs
•-GFR<30 ml/min
•-Ongoing treatment with DPP-IV antagonists
•-Liver cirrhosis Child B, C
•-Pregnancy, Lactation
•-Allergy against Sitagliptin

发起方